In terms of their expertise, experience, and impact on patient care, health leaders occupy an important position in our health system. These leaders are expected to provide value to their constituents, and this value is connected to moral objectives that are fundamental to the delivery of healthcare. In some cases, leaders may interpret a certain politico-medical decision, policy, or directive to interfere with these moral objectives. In these instances, leaders can either expressly object to a decision or sideline moral views while enacting these policies or directives. We present several contemporary examples of these issues as well as the experiences of health leaders. Subsequently, we review relevant sections of the Canadian College of Health Leaders' Code of Ethics to identify existing guidance. Ultimately, we conclude that more work is needed to define the role of leaders in these circumstances, as well as the limitations of any resistance.
What is the issue?
Although not formally elected officials, health leaders occupy an important role in Canada's publicly funded healthcare system. As those entrusted to make complex decisions that impact the well-being of both current and prospective patients, health leaders find themselves in a position of great responsibility as it relates to providing value-or good-to their constituents. Generally speaking, the good rendered by health leaders is in relation to the underlying moral goals of providing healthcare services in the first place. That is, healthcare itself is not value neutral; it is premised on a clear intention to benefit certain individuals or populations and to fulfill basic health-related interests that we consider morally important. This results in a dynamic that most of us already accept: healthcare services ought to accomplish certain things and ought not to be concerned with others.
In this context, most would agree that healthcare services should be directed toward and framed around certain healthrelated goals. These goals could include, among others, the prevention of disease and injury, the relief of pain and suffering, and the promotion and maintenance of health when possible. 1 The Canada Health Act very much reflects these endeavors, stating that "the primary objective of Canadian health policy is to protect, promote, and restore the physical and mental well-being of residents of Canada and to facilitate reasonable access to health services without financial or other barriers."
2 Morally, these are not arbitrary objectives; the intention is to fulfill certain ethical responsibilities inherent to therapeutic relationships. In the absence of this dynamic, healthcare services would be more transactional in nature, without any reference to constraining moral concepts such as rights and obligations. Given this reality, our intent in this article is to explore the ways in which a health leader should act when there is uncertainty or disagreement between leaders, the public, or political representatives about how to fulfill these moral objectives.
Specifically, the question we aim to address is whether health leaders have a role to play in advocating for or against certain politico-medical actions that are perceived to interfere with or undermine the moral objectives that health leaders believe ought to be pursued. By politico-medical, we mean those actions taken by a branch of government that result in changes to policy or the law, and that will affect health leaders, professionals, or patients. In these circumstances, it is unclear whether a leader should actively advocate for particular moral interests or against others. Despite there being no consensus on exactly what good healthcare should aim to provide, and without adequate space to investigate such aims, we will refer to the general health-related goals listed above as an acceptable starting point for goals that healthcare, in general, ought to accomplish. Our intention here is to review several contemporary cases that illustrate this difficulty, and to evaluate existing guidance that is provided to health leaders through the Canadian College of Health Leaders' (CCHL) Code of Ethics.
executive order banning travel from a number of Muslimmajority countries in early 2017. In one prominent story, a Sudanese physician travelling to work at the Cleveland Clinic was detained in New York before being returned to Saudi Arabia. 3 The Cleveland Clinic, which has historically held fundraising activities at President Trump's "Mar-a-Lago" resort in Florida, received pressure via an open letter asking that the fundraiser no longer occur at this location. 4 This open letter, which received over 1,700 signatures, makes the case that the travel ban harms "human health and well-being" and that the organization cannot "reconcile supporting its employees and patients while simultaneously financially and publicly aiding an individual who directly harms them." 5 This letter also demanded a public statement from the Cleveland Clinic condemning the travel ban. This case raises questions about the exact role of health leaders to resist a contentious policy directive created by an elected branch of government. In this case, the resistance could include condemnation of a national travel ban policy on the grounds that it undermines health-related objectives by preventing qualified healthcare professionals from delivering necessary services. Notably, this risk to patients is not just hypothetical with this issue. Cases have been reported of children who had life-saving surgeries cancelled due to President Trump's initial travel ban and who had to travel to Canada to receive care. 6 Ultimately, the Cleveland Clinic and other prominent organizations (including the American Cancer Society) later withdrew from events at Mara-Lago in August 2017, subsequent to tragic events that unfolded in Charlottesville, Virginia, and the President's controversial response to white nationalist violence. 7 Similar to their American counterparts, Canadian health leaders have also struggled with management of politically contentious issues. Perhaps one of the most relevant recent examples is the decriminalization of Medical Assistance in Dying (MAID). Beginning with a ruling by the Supreme Court of Canada, this issue evolved both legally and politically over the course of several years. During this time, the Federal government engaged in public consultation that included solicitation of input from healthcare providers and leaders, among others. Currently, legislation allows the legal provision of MAID to patients meeting specific eligibility criteria. While many healthcare organizations implemented processes to facilitate patient access, other organizations adopted a type of institutional conscientious objection. In some cases, including the experience of many Catholic organizations, the objection has been religious in nature. 8 In other cases, hospice and other palliative care organizations have appealed to more philosophical objections based on organizational values, objectives, or traditions. 9 In these cases, the main argument appears to be that MAID does not align with the goals that healthcare-either in general or as it relates to a particular health service (ie, palliative care)-should be fulfilling for patients.
A final example involves the impending legalization of marijuana by the Canadian Federal government. Although medical marijuana has been legal in Canada for a number of years, the current Liberal government intends to legalize recreational marijuana by July 2018. Notably, this initiative was a clear element of the current government's platform leading up to the Federal election in 2015, where the Liberal party won a majority government. 10 In addition, marijuana legalization has received broad public support, with a 2016 Nanos poll finding that 68% of poll respondents either "support" or "somewhat support" legalizing the recreational use of marijuana. 11 Unlike the issue of MAID, however, specific legislation on this topic is still being debated, and these debates have included dissension from some health leaders. As one example, the Canadian Medical Association Journal published a strongly worded editorial arguing against the proposed Bill C-45, also known as The Cannabis Act. In part, this editorial states that the "purported purpose of the act is to protect public health and safety, yet some of the act's provisions appear starkly at odds with this objective, particularly for Canada's youth." 12 The editorial concludes by arguing that if "Parliament truly cares about the public health and safety of Canadians, especially our youth, this bill will not pass."
12 Health leaders at the institutional level have also raised concern about the impact of legislation on patients. 13 Although still a developing issue legislatively, health leaders in this case have again expressed strong concern that a public policy could interfere with the goals that healthcare ought to pursue.
Guidance for health leaders
These types of circumstances were clearly contemplated by the authors of the CCHL Code of Ethics. The CCHL is a national non-profit organization with diverse membership from different health sectors, whose mission is to "develop, promote, advance, and recognize excellence in health leadership." 14 In a section of the Code of Ethics titled "Responsibilities to Community and Society," it is stated that leaders should "Where indicated, seek, by lawful means, changes in policies and practices that adversely impact the health of the community and society." 15 Based on this language, health leaders should be active in their advocacy when the pursuit of health-related objectives is endangered. Notably, this framework also makes no distinction between policies or practices that have already been legitimated through a democratic process, and those that have not. Rather, this code presents the health leader as being in an important position to enhance, or even adjudicate, discussions about complex policy items. Presumably, this would include discussions that involve disagreements about the moral worthiness of certain policy objectives, such as the issues noted above.
What is less clear from this guidance is the limitation of such advocacy. At what point are health leaders expected to stop pursuing a certain moral view of health services and start enacting policies or practices? On the one hand, not limiting the advocacy role of health leaders would empower leaders to continuously leverage their expertise, experience, and professional views in pursuit of policies that align with certain moral viewpoints. Under this model, ongoing refusal to provide a legal service such as MAID can be seen as a defensible position, because health leaders are advocating for a certain conception of "good" that healthcare services should embody. This could result in a marketplace of ideas being publicly advocated by different health leaders, which in turn could enhance debate, discussion, and decision-making.
On the other hand, unlimited advocacy could be problematic in the sense that it could itself undermine the types of moral goals that leaders might be trying to protect. For example, refusal to provide MAID could be seen as interfering with access to a legal service, and ensuring access to service might be one of the core moral priorities in providing healthcare. This also points to a more general problem with lack of limitations: health leaders do not agree on many of these issues. If these disagreements were unconstrained and continued to result in different approaches to different policy issues, then the patient experience could be jeopardized by barriers that exist at the level of health leadership and not policy. In a publicly funded system built on principles such as universality, portability, and accessibility, this becomes a difficult position to defend.
Conclusion
Ultimately, the health leader is in a difficult position. On one hand, we could say that leaders should simply enact the policies that have already been decided on through the democratic process because the directive in question has already been legitimated. This could result in a leader knowingly doing something they believe is morally questionable in the sense that it does not align with the fundamental ethical tenets of healthcare. Alternatively, leaders could disagree with or resist these directions because, in their view, they are not representative of morally appropriate goals. Depending on the degree of resistance, this could impact patients, result in inequitable services, and in the process actually undermine the types of moral goals that leaders might be trying to protect. However, the public may expect health leaders to inform public discourse by offering their expertise and insight. Given the types of complex politico-medical issues currently being contemplated, implemented, or decided upon by our governments and citizenry, we believe the role and expectations of health leaders require further clarification.
